𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis A in French Hemophiliacs

✍ Scribed by Dr. J. Goudemand; A. Parquet; R. D'Oiron; N. Stieltjes; C. Guérois; J. Fonlupt; M. Alcalay; C. Négrier; J.P. Cazenave; M.E. Briquel; E. Fressinaud


Book ID
115110071
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
385 KB
Volume
67
Category
Article
ISSN
0042-9007

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Hepatitis E virus infection in hemophili
✍ Asher Barzilai; Sam Schulman; Yuory V. Karetnyi; Michael O. Favorov; Edit Levin; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

## Abstract Israel is endemic for hepatitis E virus (HEV), the causative agent of enteric non‐A, non‐B hepatitis. Transmission is via the feco‐oral route but the possibility of transmission through blood transfusion has been raised. This question was addressed by examining sera from 188 hemophilic

Treatment of hepatitis C in hemophiliacs
✍ Massimo Franchini; Nicoletta Nicolini; Franco Capra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB
Hepatitis b virus, hepatitis a virus and
✍ R. J. Gerety; M. E. Eyster; E. Tabor; J. A. Drucker; C. J. Lusch; D. Prager; S. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

## Abstract To determine the exposure to hepatitis A and hepatitis B viruses (HAV, HBV) following intravenous replacement therapy in patients with classic hemophilia and to assess the role of these viruses in persistently elevated aminotransferases, sera were studied from 136 patients from 9 months

Hepatitis C virus genotypes in belgian h
✍ Li Sheng; Marc Willems; Kathelijne Peerlinck; Prof. Dr. Sing Hiem Yap; Jozef Ver 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB 👁 1 views

## Abstract Hemophiliacs who have been exposed to un‐heated and/or dry heated pooled clotting factor concentrates are at a high risk of chronic hepatitis C. Serum HCV‐RNA was measured by reverse transcriptase‐polymerase chain reaction (RT‐PCR) technique in 58 hemophiliacs positive for anti‐HCV anti